01 1Reliance Life Sciences Private Limited
01 1SUNITINIB MALATE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-10-28
Pay. Date : 2022-09-23
DMF Number : 29014
Submission : 2015-03-04
Status : Active
Type : II
20
Reliance Life Sciences Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is SUNITINIB MALATE, with a corresponding US DMF Number 29014.
Remarkably, this DMF maintains an Active status since its submission on March 04, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 28, 2022, and payment made on September 23, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
